Ignite Creation Date:
2025-12-24 @ 11:07 PM
Ignite Modification Date:
2026-03-12 @ 2:43 AM
Study NCT ID:
NCT02747069
Status:
SUSPENDED
Last Update Posted:
2018-05-17
First Post:
2016-02-25
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
HeartLight Pulse Study: Evaluation of Heart Rate Using an Electronic Stethoscope and Pre Placed ECG in the Delivery Room
Sponsor:
University of Nottingham
Organization:
Study Overview
Official Title:
Determination of Heart Rate in Neonates on the NICU and Delivery Suite Using ECG and Electronic Stethoscope, a Feasibility Study
Status:
SUSPENDED
Status Verified Date:
2018-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
New data available in public domain requires re-evaluation of protocol.
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
HLPulseS
Brief Summary:
This study will evaluate the accuracy of both an electronic stethoscope and electrocardiogram (ECG) to evaluate heart rate in neonatal patients in the delivery suite.
The initial phase of this study will assess the electronic stethoscope use on stable neonates on the neonatal care prior to use in the delivery room.
The initial phase of this study will assess the electronic stethoscope use on stable neonates on the neonatal care prior to use in the delivery room.
Detailed Description:
Up to 10% of newborns (79K/yr in United Kingdom, 13 million/yr worldwide) require some form of resuscitation at birth. It is estimated that approximately 7 million babies worldwide, especially the premature group, will require more advanced resuscitation. The correct, structured management of the resuscitation in the few 'golden' minutes after birth is critical to prevent significant morbidity (e.g. cerebral palsy due to asphyxiation) or death. There is strong evidence that standardised resuscitation training and algorithms significantly improve newborn outcomes and could reduce mortality by 30% in certain healthcare institution. International newborn resuscitation guidelines state that "a prompt increase in heart rate remains the most sensitive indicator of resuscitation efficacy" and that the stethoscope should be the primary means of assessing heart rate (HR). Provision of an accurate and timely HR value is essential if the best care outcomes are to be achieved. Establishing the HR category allows the resuscitator to decide if the HR is \>100 bpm (suggests the baby is well or resuscitation is effective), between 60-100bpm (resuscitation required initially focusing on the airway) or \<60bpm (requires much more intensive resuscitation which could include CPR). International guidelines recommend assessing the HR every 30 seconds with a stethoscope to track changes and hence efficacy of resuscitation. However, a number of studies demonstrate that newborn healthcare providers estimate the HR category incorrectly in about 1 in 3 cases, potentially resulting in the incorrect management of the baby. There is now strong evidence linking the need for resuscitation and a poor neurodevelopmental outcome in later childhood. Indeed, a number of large cohort studies have demonstrated that even if a baby requires initial resuscitation, and no further need for on-going care, they are at an increased risk of low intelligence quotient in childhood and are less likely to have paid employment or go to University when adults.
More recently electronic stethoscopes (ES) have been used to determine heart rate variability. Several studies have shown that an ES can reliably evaluate the heart rate in adults, but only one recently published study has demonstrated its use in the neonatal patient. The advantage of using an ES over ECG and pulse oximetry is fast acquisition of HR (\<5 sec) and ease of application, both attributes are beneficial in the delivery suite scenario. Furthermore, assessment of HR by auscultation (using a stethoscope) is still the primary technique used in many settings.
ECG, an established and accurate method of monitoring HR, is rarely used in the delivery room for a number of reasons including difficulty ensuring adhesion to the skin (the baby is wet/covered in vernix) and skin damage in premature babies caused by stripping of the electrodes. Current ECG systems also require 3 electrodes to be positioned which can delay resuscitation further. To improve HR assessment at birth we aim to tackle this problem through a variety of means. ECG is not routinely used for delivery room resuscitations mainly due to the impracticalities of attaching the electrodes and setting up the system. Current NICU practice is to place the ECG electrodes onto the baby's chest. It is also possible for the electrodes to be placed on the baby's which is a method commonly adopted on the NICU. Preterm babies are routinely delivered into a plastic bags/wraps to minimise heat loss. By pre-placing the ECG electrodes onto the back of the bag/wrap with small conducting holes in, it should be possible to place the baby onto the bag and connect with the ECG electrodes with a routinely used clinical conducting gel. The baby could be placed onto them and time would be saved by not needing to stick the electrodes on individually and utilising the baby's weight to establish the electrode connections. This would avoid the need to place them individually, which is often time consuming and challenging as they don't still well to wet skin, and avoid skin stripping when removed later.
This study will initially assess the accuracy and reliability of an electronic stethoscopes to evaluate heart rate on stable patients on the neonatal unit compared to routine ECG and pulse oximetry measurements. This will allow comparison of the pre placed ECG system in the second phase of the study.
More recently electronic stethoscopes (ES) have been used to determine heart rate variability. Several studies have shown that an ES can reliably evaluate the heart rate in adults, but only one recently published study has demonstrated its use in the neonatal patient. The advantage of using an ES over ECG and pulse oximetry is fast acquisition of HR (\<5 sec) and ease of application, both attributes are beneficial in the delivery suite scenario. Furthermore, assessment of HR by auscultation (using a stethoscope) is still the primary technique used in many settings.
ECG, an established and accurate method of monitoring HR, is rarely used in the delivery room for a number of reasons including difficulty ensuring adhesion to the skin (the baby is wet/covered in vernix) and skin damage in premature babies caused by stripping of the electrodes. Current ECG systems also require 3 electrodes to be positioned which can delay resuscitation further. To improve HR assessment at birth we aim to tackle this problem through a variety of means. ECG is not routinely used for delivery room resuscitations mainly due to the impracticalities of attaching the electrodes and setting up the system. Current NICU practice is to place the ECG electrodes onto the baby's chest. It is also possible for the electrodes to be placed on the baby's which is a method commonly adopted on the NICU. Preterm babies are routinely delivered into a plastic bags/wraps to minimise heat loss. By pre-placing the ECG electrodes onto the back of the bag/wrap with small conducting holes in, it should be possible to place the baby onto the bag and connect with the ECG electrodes with a routinely used clinical conducting gel. The baby could be placed onto them and time would be saved by not needing to stick the electrodes on individually and utilising the baby's weight to establish the electrode connections. This would avoid the need to place them individually, which is often time consuming and challenging as they don't still well to wet skin, and avoid skin stripping when removed later.
This study will initially assess the accuracy and reliability of an electronic stethoscopes to evaluate heart rate on stable patients on the neonatal unit compared to routine ECG and pulse oximetry measurements. This will allow comparison of the pre placed ECG system in the second phase of the study.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: